Biosense Webster Revenue and Competitors
Estimated Revenue & Valuation
- Biosense Webster's estimated annual revenue is currently $1.7B per year.
- Biosense Webster's estimated revenue per employee is $251,000
Employee Data
- Biosense Webster has 6669 Employees.
Biosense Webster's People
Name | Title | Email/Phone |
---|---|---|
1 | Area VP Sales | Reveal Email/Phone |
2 | Executive Admin to VP Human Resources | Reveal Email/Phone |
3 | Executive Assistant to VP R&D | Reveal Email/Phone |
4 | VP Quality & Compliance | Reveal Email/Phone |
5 | Director, Global Clinical Operations | Reveal Email/Phone |
6 | Director Medical Affairs | Reveal Email/Phone |
7 | Sr. Director, Strategic Partnerships | Reveal Email/Phone |
8 | Director | Reveal Email/Phone |
9 | Regional Business Director | Reveal Email/Phone |
10 | Regional Business Director | Reveal Email/Phone |
Biosense Webster Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11470M | 53604 | 4% | $6.3B | $63.9B |
What Is Biosense Webster?
Biosense Webster is recognized worldwide as a leader in the science behind the diagnosis and treatment of cardiac arrhythmias.The first useful deflectable tip catheter was pioneered by Will Webster more than three decades ago. Ever since, Biosense Webster has defined the state of design and craftsmanship in diagnostic and therapeutic cardiac catheters. In fact, we offer more electrophysiology catheter designs than anyone else in the industry. But beyond numbers, our continuous pursuit of practical innovation has led to a steady flow of breakthrough designs.
keywords:N/AN/A
Total Funding
6669
Number of Employees
$1.7B
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Biosense Webster News
Biosense Webster, Inc. CardioFocus, Inc. CathEffects Inc. themobility.club...
Abbott Laboratories (U.S.), Biosense Webster, Inc. (U.S.), BIOTRONIK SE & Co. KG (Germany), Boston Scientific Corporation (U.S.),...
Carto Prime is a 3D mapping technology for cardiac imaging developed by Johnson & Johnson's subsidiary Biosense Webster.
Investment bank Roth Capital Partners upgraded shares of AtriCure Inc. (NSDQ:ATRC) to “Buy” and raised its target price by nearly 30 percent. AtriCure, a cardiac surgical device maker, will enter “a new phase” during the next two years in which its growth rate will improve, according to a new r ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2549.6M | 6745 | 7% | N/A |
#2 | $2365.8M | 6954 | 5% | N/A |
#3 | $2071.6M | 7218 | -2% | N/A |
#4 | $1544.8M | 11034 | 4% | N/A |
#5 | $4751.8M | 12571 | 8% | N/A |